Bilateral endogenous endophthalmitis from asymptomatic Aspergillus niger fungal infective endocarditis in the immunosuppressed patient: A case report

免疫抑制患者无症状黑曲霉真菌感染性心内膜炎并发双侧内源性眼内炎:病例报告

阅读:1

Abstract

RATIONALE: Endogenous fungal endophthalmitis (EFE) is a rare but sight- and life-threatening condition that often arises in immunocompromised patients. While Aspergillus fumigatus is the predominant pathogen, Aspergillus niger-associated endocarditis leading to bilateral EFE has not been previously reported. PATIENT CONCERNS: A 51-year-old woman with a history of two renal transplants over the past 30 years, along with diabetes mellitus, hypertension, and ongoing immunosuppressive therapy, presented with rapidly progressive bilateral visual impairment, beginning with acute vision loss and ocular pain in the right eye, followed by involvement of the left eye within two days. She had no systemic symptoms such as fever, chest pain, or dyspnea. DIAGNOSIS: Initial aqueous humor analysis, including Gram staining, fungal culture, and viral PCR, yielded negative results. As the disease progressed to bilateral involvement within 2 days, a diagnostic vitrectomy was performed. Vitreous sampling demonstrated fungal hyphae, and culture confirmed Aspergillus niger. Transesophageal echocardiography further revealed mitral valve vegetation, establishing the diagnosis of fungal infective endocarditis with bilateral endogenous endophthalmitis. INTERVENTIONS: The patient received empiric intravitreal antibiotics and antivirals initially, followed by diagnostic pars plana vitrectomy and systemic antifungal therapy after identification of Aspergillus. Mitral valve replacement surgery was subsequently performed. OUTCOMES: Despite surgical intervention and systemic antifungal treatment, the patient developed disseminated fungal sepsis and died 2 weeks after valve replacement. LESSONS: This case highlights the diagnostic challenges of EFE and emphasizes the importance of considering fungal endocarditis as a source of infection in immunosuppressed patients presenting with severe vitritis, even in the absence of systemic symptoms. Early recognition, prompt vitrectomy with intravitreal antifungal therapy, and thorough systemic evaluation are essential to improve visual and systemic outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。